跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,260 条关于
“mutant KRAS”
全部
3,260
临床试验
1,916
药物
323
机构
8
资讯
1,013
去年
Avutometinib and Defactinib Show Promise in Recurrent Low-Grade Serous Ovarian Cancer
4天前
FDA Grants Fast Track Designation to Kestrel's Oral Pan-KRAS Inhibitor KST-6051 for KRAS-Mutant Solid Tumors
上个月
BBOT Advances Triple KRAS-PI3Kα Pipeline with Dual Combination Dosing, Reports $344M Cash Runway into 2028
去年
Avutometinib Plus Defactinib NDA Filed for KRAS-Mutant Low-Grade Serous Ovarian Cancer
4个月前
Quadruple Immunotherapy Shows Durable Complete Response in MSS Metastatic Colorectal Cancer but Lacks Reproducibility
6个月前
Sino Biopharmaceutical Receives NMPA Approval for Pan-KRAS Inhibitor TQB3205 Clinical Trial
去年
Elicio Therapeutics Completes Enrollment in Phase 2 Trial of ELI-002 for mKRAS-Driven Pancreatic Cancer
9个月前
Pelareorep Shows 33% Response Rate in KRAS-Mutant Colorectal Cancer, Tripling Standard-of-Care Outcomes
8个月前
Merck Launches Phase 3 KANDLELIT-007 Trial for Calderasib-KEYTRUDA QLEX Combination in KRAS G12C-Mutant Lung Cancer
去年
Novel PROTAC Degrader ACBI3 Shows Efficacy Against Multiple KRAS Mutant Cancers
第 1 页,共 102 页
上一页
下一页